Shared blood and muscle CD8+ T-cell expansions in inclusion body myositis

Brain

Volumn 129, Issue 4, 2006, Pages 986-995

  Dimitri, Dalia ^a   Benveniste, Olivier ^a   Dubourg, Odile ^a   Maisonobe, Thierry ^a   Eymard, Bruno ^a   Amoura, Zahir ^a   Jean, Laetitia ^c   Tiev, Kiet ^b   Piette, Jean Charles ^a   Klatzmann, David ^a   Herson, Serge ^a   Boyer, Olivier ^c  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^b HÔPITAL SAINT ANTOINE   (France)

^c INSERM   (France)

Author keywords

Inclusion body myositis; T cell immunology; T cell receptors

Indexed keywords

INTERLEUKIN 2; T LYMPHOCYTE RECEPTOR;

ADULT; AGED; ANALYTIC METHOD; ANALYTICAL ERROR; ARTICLE; AUTOIMMUNITY; BLOOD ANALYSIS; BLOOD LEVEL; CD8+ T LYMPHOCYTE; CELL CLONE; CELL INFILTRATION; CLINICAL ARTICLE; COMPARATIVE STUDY; COMPLEMENTARITY DETERMINING REGION; CONNECTIVE TISSUE DISEASE; CONTROLLED STUDY; DERMATOMYOSITIS; FEMALE; HUMAN; INCLUSION BODY MYOSITIS; MALE; MUSCLE; MYOSITIS; POLYMYOSITIS; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SYSTEMIC SCLEROSIS; T LYMPHOCYTE;

AGED; AGED, 80 AND OVER; AUTOIMMUNE DISEASES; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CELL MOVEMENT; CELLS, CULTURED; COMPLEMENTARITY DETERMINING REGIONS; FEMALE; HUMANS; INTERLEUKIN-2; LYMPHOCYTE ACTIVATION; MALE; MIDDLE AGED; MUSCLE, SKELETAL; MYOSITIS, INCLUSION BODY; SEVERITY OF ILLNESS INDEX; T-LYMPHOCYTE SUBSETS;

EID: 33645085045     PISSN: 00068950     EISSN: 14602156     Source Type: Journal    
DOI: 10.1093/brain/awl020     Document Type: Article

References (42)

1. Amemiya K, Granger RP, Dalakas MC. Clonal restriction of T-cell receptor expression by infiltrating lymphocytes in inclusion body myositis persists over time. Studies in repeated muscle biopsies. Brain 2000; 123: 2030-9.
2. Arahata K, Ishihara T, Fukunaga H, Orimo S, Lee JH, Goto K, et al. Inflammatory response in facioscapulohumeral muscular dystrophy (FSHD): immunocytochemical and genetic analyses. Muscle Nerve 1995; 2: S56-66.
3. Askanas V, Engel WK. Inclusion-body myositis and myopathies: different etiologies, possibly similar pathogenic mechanisms. Curr Opin Neurol 2002; 15: 525-31.
4. Badrising UA, Schreuder GM, Giphart MJ, Geleijns K, Verschuuren JJ, Wintzen AR, et al. Associations with autoimmune disorders and HLA class I and II antigens in inclusion body myositis. Neurology 2004; 63: 2396-8.
5. Barohn RJ, Amato AA, Sahenk Z, Kissel JT, Mendell JR. Inclusion body myositis: explanation for poor response to immunosuppressive therapy. Neurology 1995; 45: 1302-4.
6. Behrens L, Kerschensteiner M, Misgeld T, Goebels N, Wekerle H, Hohlfeld R. Human muscle cells express a functional costimulatory molecule distinct from B7.1 (CD80) and B7.2 (CD86) in vitro and in inflammatory lesions. J Immunol 1998; 161: 5943-51.
7. Bender A, Behrens L, Engel AG, Hohlfeld R. T-cell heterogeneity in muscle lesions of inclusion body myositis. J Neuroimmunol 1998; 84: 86-91.
8. Benveniste O, Cherin P, Maisonobe T, Merat R, Chosidow O, Mouthon L, et al. Severe perturbations of the blood T cell repertoire in polymyositis, but not dermatomyositis patients. J Immunol 2001; 167: 3521-9.
9. Benveniste O, Herson S, Salomon B, Dimitri D, Trebeden-Negre H, Jean L, et al. Long-term persistence of clonally expanded T cells in patients with polymyositis. Ann Neurol 2004; 56: 867-72.
10. Compston A, Coles A. Multiple sclerosis. Lancet 2002; 359: 1221-31.
11. Confalonieri P, Oliva L, Andreetta F, Lorenzoni R, Dassi P, Mariani E, et al. Muscle inflammation and MHC class I up-regulation in muscular dystrophy with lack of dysferlin: an immunopathological study. J Neuroimmunol 2003; 142: 130-6.
12. Dahlbom K, Lindberg C, Oldfors A. Inclusion body myositis: morphological clues to correct diagnosis. Neuromuscul Disord 2002; 12: 853-7.
13. Dalakas MC. Inflammatory disorders of muscle: progress in polymyositis, dermatomyositis and inclusion body myositis. Curr Opin Neurol 2004; 17: 561-7.
14. Dalakas MC, Koffman B, Fujii M, Spector S, Sivakumar K, Cupler E. A controlled study of intravenous immunoglobulin combined with prednisone in the treatment of IBM. Neurology 2001; 56: 323-7.
15. Fyhr IM, Moslemi AR, Tarkowski A, Lindberg C, Oldfors A. Limited T-cell receptor V gene usage in inclusion body myositis. Scand J Immunol 1996; 43: 109-14.
16. Fyhr IM, Moslemi AR, Mosavi AA, Lindberg C, Tarkowski A, Oldfors A. Oligoclonal expansion of muscle infiltrating T cells in inclusion body myositis. J Neuroimmunol 1997; 79: 185-9.
17. Fyhr IM, Moslemi AR, Lindberg C, Oldfors A. T cell receptor beta-chain repertoire in inclusion body myositis. J Neuroimmunol 1998; 91: 129-34.
18. Goebels N, Michaelis D, Engelhardt M, Huber S, Bender A, Pongratz D, et al. Differential expression of perform in muscle-infiltrating T cells in polymyositis and dermatomyositis. J Clin Invest 1996; 97: 2905-10.
19. Greenberg SA, Sanoudou D, Haslett JN, Kohane IS, Kunkel LM, Beggs AH, et al. Molecular profiles of inflammatory myopathies. Neurology 2002; 59: 1170-82.
20. Griggs RC, Askanas V, DiMauro S, Engel A, Karpati G, Mendell JR, et al. Inclusion body myositis and myopathies. Ann Neurol 1995; 38: 705-13.
21. Hofbauer M, Wiesener S, Babbe H, Roers A, Wekerle H, Dornmair K, et al. Clonal tracking of autoaggressive T cells in polymyositis by combining laser microdissection, single-cell PCR, and CDR3-spectratype analysis. Proc Natl Acad Sci USA 2003; 100: 4090-5.
22. Hohlfeld R. Hunting (auto)immune T cells in neuroimmunological diseases. Brain 2003; 126: 2-4.
23. Hohlfeld R, Engel AG. The immunobiology of muscle. Immunol Today 1994; 15: 269-74.
24. Hoogendijk JE, Amato AA, Lecky BR, Choy EH, Lundberg IE, Rose MR, et al. 119th ENMC international workshop: trial design in adult idiopathic inflammatory myopathies, with the exception of inclusion body myositis, 10-12 October 2003, Naarden, The Netherlands. Neuromuscul Disord 2004; 14: 337-45.
25. Koffman BM, Rugiero M, Dalakas MC. Immune-mediated conditions and antibodies associated with sporadic inclusion body myositis. Muscle Nerve 1998; 21: 115-7.
26. Lindberg C, Oldfors A, Tarkowski A. Restricted use of T cell receptor V genes in endomysial infiltrates of patients with inflammatory myopathies. Eur J Immunol 1994; 24: 2659-63.
27. Mantegazza R, Andreetta F, Bernasconi P, Baggi F, Oksenberg JR, Simoncini O, et al. Analysis of T cell receptor repertoire of muscle-infiltrating T lymphocytes in polymyositis. Restricted V alpha/beta rearrangements may indicate antigen-driven selection. J Clin Invest 1993; 91: 2880-6.
28. van der Meulen MF, van Wichen DF, van Blokland WT, van den Berg LH, Wokke JH, Hoogendijk JE, et al. Evidence for heterogeneity of T cell expansion in polymyositis and inclusion body myositis. J Neuroimmunol 2002; 133: 198-204.
29. Muntzing K, Lindberg C, Moslemi AR, Oldfors A. Inclusion body myositis: clonal expansions of muscle-infiltrating T cells persist over time. Scand J Immunol 2003; 58: 195-200.
30. Murata K, Dalakas MC. Expression of the costimulatory molecule BB-1, the ligands CTLA-4 and CD28, and their mRNA in inflammatory myopathies. Am J Pathol 1999a; 155: 453-60.
31. Murata K, Dalakas MC. Expression of the costimulatory molecule BB-I, the ligands CTLA-4 and CD28, and their mRNA in inflammatory myopathies. Am J Pathol 1999b; 155: 453-60.
32. Nishio J, Suzuki M, Miyasaka N, Kohsaka H. Clonal biases of peripheral CD8 T cell repertoire directly reflect local inflammation in polymyositis. J Immunol 2001; 167: 4051-8.
33. Noseworthy JH, Lucchinetti C, Rodriguez M, Weinshenker BG. Multiple sclerosis. N Engl J Med 2000; 343: 938-52.
34. O'Hanlon TP, Dalakas MC, Plotz PH, Miller FW. The alpha beta T-cell receptor repertoire in inclusion body myositis: diverse patterns of gene expression by muscle-infiltrating lymphocytes. J Autoimmun 1994a; 7: 321-33.
35. O'Hanlon TP, Dalakas MC, Plotz PH, Miller FW. Predominant TCR-alpha beta variable and joining gene expression by muscle-infiltrating lymphocytes in the idiopathic inflammatory myopathies. J Immunol 1994b; 152: 2569-76.
36. Orimo S, Koga R, Goto K, Nakamura K, Arai M, Tamaki M, et al. Immunohistochemical analysis of perform and granzyme A in inflammatory myopathies. Neuromuscul Disord 1994; 4: 219-26.
37. Pannetier C, Cochet M, Darche S, Casrouge A, Zoller M, Kourilsky P. The sizes of the CDR3 hypervariable regions of the murine T-cell receptor beta chains vary as a function of the recombined germ-line segments. Proc Natl Acad Sci USA 1993; 90: 4319-23.
38. Pannetier C, Even J, Kourilsky P. T-cell repertoire diversity and clonal expansions in normal and clinical samples. Immunol Today 1995; 16: 176-81.
39. Posnett DN, Sinha R, Kabak S, Russo C. Clonal populations of T cells in normal elderly humans: the T cell equivalent to 'benign monoclonal gammapathy'. J Exp Med 1994; 179: 609-18.
40. Pruitt JNII, Showalter CJ, Engel AG. Sporadic inclusion body myositis: counts of different types of abnormal fibers. Ann Neurol 1996; 39: 139-43.
41. Schwab R, Szabo P, Manavalan JS, Weksler ME, Posnett DN, Pannetier C, et al. Expanded CD4+ and CD8+ T cell clones in elderly humans. J Immunol 1997; 158: 4493-9.
42. Tiev KP, Abriol J, Burland MC, Antonelli D, Klatzmann D, Cabane J, et al. T cell repertoire in patients with stable scleroderma. Clin Exp Immunol 2005; 139: 348-54.